Publication | Closed Access

Comparison of Efficacy and Safety of Atorvastatin (80 mg) to Simvastatin (20 to 40 mg) in Patients Aged <65 Versus ≥65 Years With Coronary Heart Disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] Study)

Versus ≥65Incremental DecreaseLipid DisorderCardiovascular DiseaseHyperlipidemiaAnesthesiologyDyslipidemiaPublic HealthMedicineCardiologyEpidemiologyCoronary Artery DiseaseCoronary Heart Disease